A high dairy protein, high-calcium diet minimizes bone turnover in overweight adults during weight loss
Recently, the dual GIPR/GLP-1R co-agonist, tirzepatide, has demonstrated a marked effect on body weight in individuals with overweight and obesity, and Phase III trials of this drug are expected to be completed in 2023 [28]
tested the code "MOBILE10" at checkout on bmimd.com
In comparison, patients with lower metabolic levels experience the appetite-suppressing effect of semaglutide for a longer time
Within three months, 83% reported statistically significant drops in lactate threshold pace, and 68% experienced what coaches described as 'inexplicable bonking' during previously manageable long runs
Ill also share insights from how I cured my methane SIBO years ago, the journey that ultimately inspired the work we do now to help others